Mera Pharmaceuticals Inc
Mera Pharmaceuticals, Inc. focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology. The company is also involved in the development of sea salt; and operation of family entertainment center focused on promoting health and wellness through the Villari's system of martial arts. In addition, it provides foo… Read more
Mera Pharmaceuticals Inc (MRPI) - Total Assets
Latest total assets as of July 2021: $0.00 USD
Based on the latest financial reports, Mera Pharmaceuticals Inc (MRPI) holds total assets worth $0.00 USD as of July 2021.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Mera Pharmaceuticals Inc - Total Assets Trend (1996–2011)
This chart illustrates how Mera Pharmaceuticals Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Mera Pharmaceuticals Inc - Asset Composition Analysis
Current Asset Composition (October 2011)
Mera Pharmaceuticals Inc's total assets of $0.00 consist of 77.1% current assets and 22.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 6.1% |
| Accounts Receivable | $7.85K | 11.1% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $2.02K | 2.9% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1996–2011)
This chart illustrates how Mera Pharmaceuticals Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Mera Pharmaceuticals Inc's current assets represent 77.1% of total assets in 2011, an increase from 48.2% in 1996.
- Cash Position: Cash and equivalents constituted 6.1% of total assets in 2011, down from 47.4% in 1996.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1996.
- Asset Diversification: The largest asset category is accounts receivable at 11.1% of total assets.
Mera Pharmaceuticals Inc Competitors by Total Assets
Key competitors of Mera Pharmaceuticals Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Mera Pharmaceuticals Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Mera Pharmaceuticals Inc generates 4.28x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Mera Pharmaceuticals Inc is currently not profitable relative to its asset base.
Mera Pharmaceuticals Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.00 | 0.02 | 0.13 |
| Quick Ratio | 0.00 | 0.02 | 0.13 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-38.65K | $ -739.54K | $ -416.66K |
Mera Pharmaceuticals Inc - Advanced Valuation Insights
This section examines the relationship between Mera Pharmaceuticals Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -3.6% |
| Total Assets | $70.68K |
| Market Capitalization | $1.00 USD |
Valuation Analysis
Below Book Valuation: The market values Mera Pharmaceuticals Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Mera Pharmaceuticals Inc's assets decreased by 3.6% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Mera Pharmaceuticals Inc (1996–2011)
The table below shows the annual total assets of Mera Pharmaceuticals Inc from 1996 to 2011.
| Year | Total Assets | Change |
|---|---|---|
| 2011-10-31 | $70.68K | -3.65% |
| 2010-10-31 | $73.36K | -71.51% |
| 2009-10-31 | $257.50K | -34.76% |
| 2008-10-31 | $394.71K | -82.27% |
| 2007-10-31 | $2.23 Million | -8.49% |
| 2006-10-31 | $2.43 Million | -6.97% |
| 2005-10-31 | $2.61 Million | -20.22% |
| 2004-10-31 | $3.28 Million | -23.19% |
| 2003-10-31 | $4.27 Million | -22.71% |
| 2002-10-31 | $5.52 Million | +33.39% |
| 2001-10-31 | $4.14 Million | +2.59% |
| 2000-10-31 | $4.03 Million | +12.06% |
| 1999-10-31 | $3.60 Million | +31.47% |
| 1998-10-31 | $2.74 Million | +199.32% |
| 1997-10-31 | $914.80K | -33.13% |
| 1996-10-31 | $1.37 Million | -- |